Immune-preserving radiotherapy and perioperative immunotherapy in stage III NSCLC: a narrative review of current management and future directions for IIIA/IIIB NSCLC.
- DOI
- 10.21037/tlcr-2025-aw-1135
- Published
- 2026 Jul 31
- Container
- Translational lung cancer research
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.21037/tlcr-2025-aw-1135,
title = {Immune-preserving radiotherapy and perioperative immunotherapy in stage III NSCLC: a narrative review of current management and future directions for IIIA/IIIB NSCLC.},
author = {Chow Z and Simone CB 2nd and Lin H and Yang J and Bernard M and Yan W},
year = {2026},
journal = {Translational lung cancer research},
doi = {10.21037/tlcr-2025-aw-1135},
url = {https://doi.org/10.21037/tlcr-2025-aw-1135}
}RIS
TY - JOUR TI - Immune-preserving radiotherapy and perioperative immunotherapy in stage III NSCLC: a narrative review of current management and future directions for IIIA/IIIB NSCLC. AU - Chow Z AU - Simone CB 2nd AU - Lin H AU - Yang J AU - Bernard M AU - Yan W PY - 2026 JO - Translational lung cancer research DO - 10.21037/tlcr-2025-aw-1135 UR - https://doi.org/10.21037/tlcr-2025-aw-1135 ER -
APA
Z, C., 2nd, S. C., H, L., J, Y., M, B., & W, Y. (2026). Immune-preserving radiotherapy and perioperative immunotherapy in stage III NSCLC: a narrative review of current management and future directions for IIIA/IIIB NSCLC.. Translational lung cancer research. https://doi.org/10.21037/tlcr-2025-aw-1135
Source records
- pubmed · retrieved 2026-09-26T07:45:58.931Z